Gryphon Financial Partners LLC / ABT
Gryphon Financial Partners LLC’s Abbott Laboratories Position
Does Gryphon Financial Partners LLC own Abbott Laboratories (ABT)? Yes — 121.9K shares worth $13M (+1.28% of its 13F portfolio) as of Q1 2026, up from 120.2K shares the prior filed quarter.
Position Value
$13M
Q1 2026
Shares
121.9K
% of Portfolio
+1.28%
Quarters Held
30
currently held
Position History ABT
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 121.9K | $13M | +1.28% |
| Q4 2025 | 120.2K | $15M | +1.61% |
| Q3 2025 | 118.6K | $16M | +1.81% |
| Q2 2025 | 120.7K | $16M | +2.14% |
| Q1 2025 | 115.2K | $15M | +2.20% |
| Q4 2024 | 114.6K | $13M | +1.85% |
| Q3 2024 | 113.9K | $13M | +1.75% |
| Q2 2024 | 113.6K | $12M | +1.77% |
| Q1 2024 | 111.4K | $13M | +2.10% |
| Q4 2023 | 111.2K | $12M | +2.16% |
| Q3 2023 | 107.4K | $10M | +2.41% |
| Q2 2023 | 109.3K | $12M | +2.58% |
| Q1 2023 | 108.8K | $11M | +2.51% |
| Q4 2022 | 108.9K | $12M | +2.84% |
| Q3 2022 | 109.1K | $11M | +2.66% |
| Q2 2022 | 107.3K | $12M | +2.83% |
| Q1 2022 | 106.4K | $13M | +2.57% |
| Q4 2021 | 105.8K | $15M | +2.82% |
| Q3 2021 | 105.9K | $13M | +2.78% |
| Q2 2021 | 104.7K | $12M | +2.73% |
| Q1 2021 | 106.0K | $13M | +2.89% |
| Q4 2020 | 78.2K | $9M | +2.21% |
| Q3 2020 | 77.6K | $8M | +2.50% |
| Q2 2020 | 80.6K | $7M | +2.29% |
| Q1 2020 | 82.6K | $7M | +2.40% |
| Q4 2019 | 84.7K | $7M | +1.91% |
| Q3 2019 | 85.1K | $7M | +2.05% |
| Q2 2019 | 85.3K | $7M | +2.07% |
| Q1 2019 | 83.7K | $7M | +1.97% |
| Q4 2018 | 85.3K | $6M | +1.57% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Gryphon Financial Partners LLC’s full portfolio or all institutional holders of ABT.